Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
30
2
3
4
5
6
7
9
12
13
14
15
17
19
22
25
27
12:00 AM - HLTH 2019
28
29
30
31
1
2
3
01 Oct
2019-10-01 - 2019-10-02    
All Day
The UK’s leading health technology and smart health event, bringing together a specialist audience of over 4,000 health and care professionals covering IT and clinical [...]
08 Oct
2019-10-08 - 2019-10-09    
12:00 am
Looking to maximize the efficiency of your current Revenue Cycle solution? Join us as we present strategies for analyzing your MEDITECH Revenue Cycle, and learn from other [...]
2019 Southwest Dental Conference
2019-10-10 - 2019-10-11    
All Day
ABOUT 2019 SOUTHWEST DENTAL CONFERENCE For 91 years, the Southwest Dental Conference has been the meeting of choice for quality professional development and innovative educational [...]
Annual Conference & Exhibition Lyotalk USA 2019
2019-10-10 - 2019-10-11    
All Day
ABOUT ANNUAL CONFERENCE & EXHIBITION LYOTALK USA 2019 Lyotalk is USA’s largest annual conference on Lyophilization/Freeze Drying. Lyotalk attracts gathering from of 150+ experts from [...]
Lab Indonesia 2019
2019-10-10 - 2019-10-12    
All Day
ABOUT LAB INDONESIA 2019 LabAsia is Southeast Asia’s leading laboratory exhibition, serving as the region’s trade platform for laboratory equipment & services suppliers to engage [...]
30th International Conference on Clinical and Experimental Ophthalmology
2019-10-11 - 2019-10-12    
All Day
ABOUT 30TH INTERNATIONAL CONFERENCE ON CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY The 30th International Conference on Clinical and Experimental Ophthalmology is going to be held during October [...]
7th International Conference on Cosmetology & Beauty 2019
Cosmetology and Beauty 2019 passionately welcomes each one of you to attend a global conference in the field of cosmetology which is held on October [...]
16 Oct
2019-10-16 - 2019-10-17    
All Day
ABOUT 17TH INTERNATIONAL CONFERENCE ON CANCER RESEARCH AND THERAPY Cancer Research Conference 2019 coordinates addressing the principal themes and in addition inevitable methodologies of oncology. [...]
Global Cardio Diabetes Conclave 2019
2019-10-18 - 2019-10-20    
All Day
ABOUT GLOBAL CARDIO DIABETES CONCLAVE 2019 A strong correlation between cardiovascular diseases and diabetes is now well established. The American Heart Association considers that individuals [...]
2019 Rehabilitation Medicine Society of Australia and New Zealand
2019-10-20 - 2019-10-23    
All Day
ABOUT 2019 REHABILITATION MEDICINE SOCIETY OF AUSTRALIA AND NEW ZEALAND On behalf of Rehabilitation Medicine Society of Australia and New Zealand (RMSANZ) and the organising [...]
21 Oct
2019-10-21 - 2019-10-23    
All Day
ABOUT GLOBAL CONFERENCE ON SURGERY AND ANESTHESIA (GCSA 2019) Global Conference on Surgery and Anesthesia (GCSA 2019) scheduled on October 21-23 2019 in Dubai, UAE [...]
21 Oct
2019-10-21 - 2019-10-22    
All Day
ABOUT 10TH INTERNATIONAL CONFERENCE ON MASS SPECTROMETRY AND CHROMATOGRAPHY ME Conferences is excited to announce the “10th International Conference on Mass Spectrometry and Chromatography” that [...]
MEDICAL JAPAN 2019 TOKYO
2019-10-23 - 2019-10-25    
All Day
ABOUT MEDICAL JAPAN 2019 TOKYO B to B Trade Show Covering All the Products/Services/Technologies in the Healthcare Industry! MEDICAL JAPAN TOKYO, a sister show of [...]
15th ACAM Laser and Cosmetic Medicine Conference 2019
2019-10-23 - 2019-10-25    
All Day
ABOUT 15TH ACAM LASER AND COSMETIC MEDICINE CONFERENCE 2019 As the new president of ACAM, I am delighted to welcome you all to the 15th [...]
23rd European Nephrology Conference
2019-10-24 - 2019-10-25    
All Day
ABOUT 23RD EUROPEAN NEPHROLOGY CONFERENCE Theme: The Imminent of Nephrology: Current & Advance Approaches to treat Kidney Diseases 23rd European Nephrology Conference is the world’s [...]
FNCE 2019 Food & Nutrition Conference & Expo
2019-10-26 - 2019-10-29    
All Day
ABOUT FNCE 2019 – FOOD & NUTRITION CONFERENCE & EXPO Experience dynamic educational opportunities not available elsewhere. Gain access to new trends, perspectives from expert [...]
HLTH 2019
2019-10-27 - 2019-10-30    
All Day
ABOUT HLTH 2019 HLTH is the largest and most important conference for health innovation. It’s an unprecedented, large-scale forum for collaboration across senior leaders from [...]
Events on 2019-10-01
01 Oct
Events on 2019-10-08
08 Oct
8 Oct 19
Massachusetts
Events on 2019-10-10
Events on 2019-10-18
Global Cardio Diabetes Conclave 2019
18 Oct 19
Bidhannagar
Events on 2019-10-23
Events on 2019-10-24
Events on 2019-10-26
Events on 2019-10-27
HLTH 2019
27 Oct 19
Las Vegas
Latest News

Factors Predicting Poor Locoregional Control in Tongue Cancer

In patients with pT1-2N0 oral tongue squamous cell carcinoma undergoing partial glossectomy and elective neck dissection, inferior locoregional control (LRC) was associated with depth of invasion, lymphovascular space invasion, and positive glossectomy specimen margins. These retrospective findings, presented at the 2024 ASTRO Multidisciplinary Head and Neck Cancers Symposium, remained significant even in cases with final negative tumor bed margins.At a median follow-up of 45.6 months, the all-comer patient population exhibited 3-year locoregional control (LRC) and overall survival (OS) rates of 88.0% and 92.5%, respectively. Among patients with pT1 disease, these rates were 92.0% and 95.2%, while in those with pT2 disease, the rates were 85.0% and 90.5%.

However, during the multivariate analysis, individuals with positive glossectomy margins exhibited poorer locoregional control (HR, 6.66; 95% CI, 1.60-27.78; P = .009). Lymphovascular space invasion (HR, 6.90; 95% CI, 1.42-33.65; P = .02) and depth of invasion (HR, 1.31; 95% CI, 1.06-1.63; P = .01) were also correlated with diminished locoregional control.

The lead study author, Michael Modzelewski, MD, along with the co-investigators, stated in a poster presented at the meeting, “Patients with these risk factors may be considered for adjuvant radiotherapy to optimize disease control.”

Individuals with early-stage tongue squamous cell carcinoma typically do not undergo adjuvant radiation due to their low recurrence risk. After surgery, the status of the primary glossectomy specimen margin has been observed to have a stronger correlation with local recurrence than the status of additional tumor bed margins, as stated by the authors.

The investigators aimed to identify the pathological factors associated with locoregional recurrence in patients with early-stage tongue squamous cell carcinoma who underwent surgery alone. Additionally, they explored the impact of a positive glossectomy specimen margin on disease control concerning final negative tumor bed margins.

The research included 110 patients diagnosed with pT1-2N0 oral tongue squamous cancer, adhering to the American Joint Committee on Cancer (AJCC) 8th edition criteria. These individuals underwent partial glossectomy and elective dissection from 2015 to 2021, excluding adjuvant radiation. Pathology reports were examined for factors such as tumor size, depth of invasion, glossectomy specimen margin, final tumor bed margin status, and perineural or lymphovascular space invasion. Individuals with positive final margins or a history of head and neck radiation were excluded.

The Kaplan-Meier method was employed to estimate locoregional control (LRC) and overall survival (OS), with a Cox proportional hazards model identifying prognostic factors for LRC in multivariate analysis.

Concerning baseline characteristics, the median age was 52 years, with the majority being male (54.5%) and having pT2 stage disease (58.2%). There were 33 lymph nodes dissected on average, and the median tumor size measured 16 mm, with a depth of invasion reaching 5 mm.

The majority of patients did not exhibit perineural invasion (84.7%), while 3.6% had lymphovascular space invasion. Positive glossectomy specimen margins were observed in 8.2% of cases.

Further findings revealed that among patients with positive glossectomy specimen margins and those without, the 3-year locoregional control (LRC) rates were 66.7% and 89.5%, respectively. Similarly, the rates were 0.0% for individuals with lymphovascular space invasion and 89.4% for those without. Among the 8 patients experiencing regional failure, 5 had recurrence in the ipsilateral neck alone (62.5%), 2 in the bilateral neck (25.0%), and 1 with isolated contralateral neck recurrence (12.5%).